Jürgen B. Bulitta

Jürgen B. Bulitta publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Jürgen B. Bulitta sits on this spectrum.

Jürgen B. Bulitta D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Jürgen B. Bulitta sits on this spectrum.

Best Publications

• Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing.

  Lauren M Lim;Neang S Ly;Dana Anderson;Jenny C Yang

  548
  Citations

• Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model

  Phillip John Bergen;Jurgen B Bulitta;Alan Forrest;Brian Tsuji

  218
  Citations

• Combination therapy for carbapenem-resistant Gram-negative bacteria

  Unknown

  192
  Citations

• Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial

  Unknown

  189
  Citations

• Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans.

  Jürgen B. Bulitta;William W. Hope;Ann E. Eakin;Tina Guina

  165
  Citations

• Synergistic Killing of Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula by Colistin Combined with Doripenem in an In Vitro Pharmacokinetic/Pharmacodynamic Model

  Phillip J. Bergen;Brian T. Tsuji;Jurgen B. Bulitta;Alan Forrest

  149
  Citations

• Attenuation of Colistin Bactericidal Activity by High Inoculum of Pseudomonas aeruginosa Characterized by a New Mechanism-Based Population Pharmacodynamic Model

  Jurgen Bernd Bulitta;Jenny C Yang;Liliana Yohonn;Liliana Yohonn;Neang S Ly

  146
  Citations

• Ertapenem Pharmacokinetics and Impact on Intestinal Microflora, in Comparison to Those of Ceftriaxone, after Multiple Dosing in Male and Female Volunteers

  Mathias W. R. Pletz;Mareike Rau;Juergen Bulitta;Andres De Roux

  146
  Citations

• Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers

  J. B. Bulitta;S. B. Duffull;M. Kinzig-Schippers;U. Holzgrabe

  135
  Citations

• The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections

  T. Tängdén;V. Ramos Martín;T. W. Felton;E. I. Nielsen

  133
  Citations

• Clinical population pharmacokinetics and toxicodynamics of linezolid

  Lauren Marie Boak;Craig Robert Rayner;M Lindsay Grayson;M Lindsay Grayson;David L Paterson

  132
  Citations

• Evaluation by Monte Carlo Simulation of the Pharmacokinetics of Two Doses of Meropenem Administered Intermittently or as a Continuous Infusion in Healthy Volunteers

  Wolfgang A. Krueger;Jurgen Bulitta;Martina Kinzig-Schippers;Cornelia Landersdorfer

  124
  Citations

• Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units

  Juliana F. Roos;Jurgen Bulitta;Jeffrey Lipman;Carl M. J. Kirkpatrick

  122
  Citations

• Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula

  Phillip J. Bergen;Alan Forrest;Jürgen B. Bulitta;Brian T. Tsuji

  116
  Citations

• Synergistic Activity of Colistin and Rifampin Combination against Multidrug-Resistant Acinetobacter baumannii in an In Vitro Pharmacokinetic/Pharmacodynamic Model

  Hee Ji Lee;Phillip John Bergen;Jurgen Bernd Bulitta;Jurgen Bernd Bulitta;Brian Tsuji

  114
  Citations

• Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa.

  Jiirgen B. Bulitta;Neang S. Ly;Jenny C. Yang;Alan Forrest

  114
  Citations

• Phase 2, Randomized, Double-Blind, Dose-Ranging Study Evaluating the Safety, Tolerability, Population Pharmacokinetics, and Efficacy of Oral Torezolid Phosphate in Patients with Complicated Skin and Skin Structure Infections

  Unknown

  111
  Citations

• Two Mechanisms of Killing of Pseudomonas aeruginosa by Tobramycin Assessed at Multiple Inocula via Mechanism-Based Modeling

  Jurgen Bernd Bulitta;Jurgen Bernd Bulitta;Neang S Ly;Cornelia Barbara Landersdorfer;Nicholin Agata Wanigaratne

  100
  Citations

• Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance

  Soon Ee Cheah;Jian Li;Brian T. Tsuji;Alan Forrest

  94
  Citations

• The Combination of Colistin and Doripenem Is Synergistic against Klebsiella pneumoniae at Multiple Inocula and Suppresses Colistin Resistance in an In Vitro Pharmacokinetic/Pharmacodynamic Model

  Zakuan Z. Deris;Heidi H. Yu;Kathryn Davis;Rachel L. Soon;Rachel L. Soon

  90
  Citations